Regulating leukotriene synthesis: The role of nuclear 5-lipoxygenase

被引:47
作者
Brock, TG [1 ]
机构
[1] Univ Michigan, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA
关键词
5-lipoxygenase; enzyme regulation; nucleus; nuclear import; leukotriene; inflammation; arachidonic acid;
D O I
10.1002/jcb.20662
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Leukotrienes are lipid messengers involved in autocrine and paracrine cellular signaling. They are synthesized from arachidonic acid by the 5-lipoxygenase pathway. Current models of this enzymatic pathway recognize that a key step in initiating leukotriene synthesis is the calcium-mediated movement of enzymes, including 5-lipoxygenase, to intracellular membranes. However, 5-lipoxygenase can be imported into or exported from the nucleus before calcium activation. As a result, its subcellular localization will affect its ability to be activated by calcium, as well as the membrane to which it binds and its interaction with other enzymes. This commentary focuses on the role of 5-lipoxygenase compartmentation in determining its regulation and, ultimately, leukotriene synthesis. J. Cell. Biochem. 96: 1203-1211, 2005. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:1203 / 1211
页数:9
相关论文
共 50 条
[31]   Hypercholesterolemia Increases the Production of Leukotriene B4 in Neutrophils by Enhancing the Nuclear Localization of 5-Lipoxygenase [J].
Lai, Xiao-Feng ;
Qin, Hua-Di ;
Guo, Lei-Lei ;
Luo, Zi-Guo ;
Chang, Jing ;
Qin, Chun-Chang .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2014, 34 (05) :1723-1732
[32]   Therapeutic options for 5-lipoxygenase inhibitors [J].
Werz, Oliver ;
Steinhilber, Dieter .
PHARMACOLOGY & THERAPEUTICS, 2006, 112 (03) :701-718
[33]   MODE OF ACTION OF THE LEUKOTRIENE SYNTHESIS (FLAP) INHIBITOR BAY-X-1005 - IMPLICATIONS FOR BIOLOGICAL REGULATION OF 5-LIPOXYGENASE [J].
HATZELMANN, A ;
FRUCHTMANN, R ;
MOHRS, KH ;
RADDATZ, S ;
MATZKE, M ;
PLEISS, U ;
KELDENICH, J ;
MULLERPEDDINGHAUS, R .
AGENTS AND ACTIONS, 1994, 43 (1-2) :64-68
[34]   5-lipoxygenase polymorphism and in-vivo response to leukotriene receptor antagonists [J].
Fowler, SJ ;
Hall, IP ;
Wilson, AM ;
Wheatley, AP ;
Lipworth, BJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 58 (03) :187-190
[35]   The molecular mechanism of the inhibition by licofelone of the biosynthesis of 5-lipoxygenase products [J].
Fischer, L. ;
Hornig, M. ;
Pergola, C. ;
Meindl, N. ;
Franke, L. ;
Tanrikulu, Y. ;
Dodt, G. ;
Schneider, G. ;
Steinhilber, D. ;
Werz, O. .
BRITISH JOURNAL OF PHARMACOLOGY, 2007, 152 (04) :471-480
[36]   Pharmacological intervention with 5-lipoxygenase: new insights and novel compounds [J].
Werz, O ;
Steinhilber, D .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2005, 15 (05) :505-519
[37]   Role of 5-lipoxygenase in the multiple organ failure induced by zymosan [J].
Cuzzocrea, S ;
Rossi, A ;
Serraino, I ;
Di Paola, R ;
Dugo, L ;
Genovese, T ;
Britti, D ;
Sciarra, G ;
De Sarro, A ;
Caputi, AP ;
Sautebin, L .
INTENSIVE CARE MEDICINE, 2004, 30 (10) :1935-1943
[38]   Cyclooxygenase and 5-lipoxygenase pathmays in the vessel wall: Role in atherosclerosis [J].
Vila, L .
MEDICINAL RESEARCH REVIEWS, 2004, 24 (04) :399-424
[39]   Interaction of ceruloplasmin and 5-lipoxygenase [J].
A. V. Sokolov ;
E. A. Golenkina ;
V. A. Kostevich ;
V. B. Vasilyev ;
G. F. Sud’ina .
Biochemistry (Moscow), 2010, 75 :1464-1469
[40]   Modulation of the 5-Lipoxygenase Pathway by Chalcogen-Containing Inhibitors of Leukotriene A4 Hydrolase [J].
Teder, Tarvi ;
Koenig, Stefanie ;
Singh, Rajkumar ;
Samuelsson, Bengt ;
Werz, Oliver ;
Garscha, Ulrike ;
Haeggstrom, Jesper Z. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (08)